Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Upgraded by Oppenheimer
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...
Ulta Beauty (NASDAQ:ULTA) Price Target Lowered to $404.00 at BMO Capital Markets
Ulta Beauty (NASDAQ:ULTA – Get Free Report) had its price target lowered by BMO Capital Markets from $467.00 to $404.00 in a ...
Charles Schwab Investment Management Inc. Grows Holdings in DXC Technology (NYSE:DXC)
Charles Schwab Investment Management Inc. raised its position in DXC Technology (NYSE:DXC – Free Report) by 3.5% in the 4th ...
moneycontrol.com16h
US Markets
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...